Last updated: November 27, 2023
Sponsor: Translational Genomics Research Institute
Overall Status: Completed
Phase
N/A
Condition
Holoprosencephaly
Neurofibromatosis
Precancerous Condition
Treatment
N/AClinical Study ID
NCT03276195
vnarayanan15-016
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of familial TSC or sporadic TSC, or a biological relative of a persondiagnosed with such a disorder.
- Willingness and ability to donate biospecimens to TGen for the purpose of propellingresearch. The minimum biospecimen donation capability is saliva and/or cheek swab. Inmost cases, blood or other tissue (skin biopsy) may be the ideal sample for study.
Exclusion
Exclusion Criteria:
- Individuals that are 18 years or older that lack the capacity to consent forthemselves.
Study Design
Total Participants: 32
Study Start date:
May 01, 2016
Estimated Completion Date:
November 27, 2023
Study Description
Connect with a study center
Translational Genomics Research Institute (TGen)
Phoenix, Arizona 85004
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.